Familial hypercholesterolemia

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F15%3A10317025" target="_blank" >RIV/00216208:11130/15:10317025 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/15:10317025 RIV/00179906:_____/15:10317025 RIV/00216208:11110/15:10317025 RIV/00064165:_____/15:10317025

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Familial hypercholesterolemia

Popis výsledku v původním jazyce

Familial Hypercholesterolemia is a book that addresses a very interesting and important type of hereditary hypercholesterolemia. Familial hypercholesterolemia (FH) represents a true example from nature that allows us to study the mechanisms of atherosclerosis development. The book begins with a description of the underlying genetic defect that leads to elevated plasma cholesterol levels, after which the authors describe the clinical presentations of FH (a color supplement is included) and underscore thesignificance of FH as a major risk factor of coronary heart disease. The book provides the reader with basic information pertaining to screening (cascade screening, above all else), diagnosis and treatment of FH. Non-pharmacologic treatment is a basic approach in FH treatment, whereas LDL-apheresis is an aggressive treatment method that is primarily used in patients with homozygous FH. However, the majority of all FH patients require pharmacologic treatment. Statins, or a statin + ezeti

Název v anglickém jazyce

Familial hypercholesterolemia

Popis výsledku anglicky

Familial Hypercholesterolemia is a book that addresses a very interesting and important type of hereditary hypercholesterolemia. Familial hypercholesterolemia (FH) represents a true example from nature that allows us to study the mechanisms of atherosclerosis development. The book begins with a description of the underlying genetic defect that leads to elevated plasma cholesterol levels, after which the authors describe the clinical presentations of FH (a color supplement is included) and underscore thesignificance of FH as a major risk factor of coronary heart disease. The book provides the reader with basic information pertaining to screening (cascade screening, above all else), diagnosis and treatment of FH. Non-pharmacologic treatment is a basic approach in FH treatment, whereas LDL-apheresis is an aggressive treatment method that is primarily used in patients with homozygous FH. However, the majority of all FH patients require pharmacologic treatment. Statins, or a statin + ezeti

Druh

B - Odborná kniha

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

ISBN

978-80-7387-953-2

Počet stran knihy

159

Název nakladatele

Triton

Místo vydání

Praha

Kód UT WoS knihy

—